Insmed Inc. buy Wells Fargo & Company
Start price
20.10.25
/
50%
€143.00
Target price
20.10.26
€146.65
Performance (%)
-19.37%
Price
08:47
?
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -19.37%. This prediction currently runs until 20.10.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 32.677% | 32.677% |
| iShares Core DAX® | 1.001% | 4.831% |
| iShares Nasdaq 100 | 2.702% | -1.720% |
| iShares Nikkei 225® | 3.519% | -3.506% |
| iShares S&P 500 | 1.766% | 1.273% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $171.00 price target on the stock.
Ratings data for INSM provided by MarketBeat